Table 1 Distribution of participants across different neuromuscular diseases
From: The most bothersome symptoms in neuromuscular diseases: the ERN EURO NMD Survey
Neuromuscular Disease | N = 11091 |
|---|---|
Charcot-Marie-Tooth disease and related neuropathies (HNNP, HSAN, dHMN) | 295 (26.6%) |
Mitochondrial Diseases | 216 (19.5%) |
Other | 111 (10%) |
Spinal Muscular Atrophy (SMA) | 70 (6.3%) |
Other Muscular Dystrophies (excluding Duchenne, Becker, FSHD, myotonic dystrophies) | 65 (5.9%) |
Facioscapulohumeral Muscular Dystrophy (FSHD) | 62 (5.6%) |
Duchenne or Becker Muscular Dystrophy | 48 (4.3%) |
Myotonic Dystrophies | 46 (4.1%) |
Myasthenia gravis | 41 (3.7%) |
Idiopathic Inflammatory Myopathies | 31 (2.8%) |
Congenital Myopathies and Congenital muscular dystrophies | 22 (2%) |
Small Fiber Neuropathies | 18 (1.6%) |
Metabolic Myopathies | 17 (1.5%) |
Congenital Myasthenic Syndromes | 14 (1.3%) |
Inflammatory and Dysimmune Neuropathies | 14 (1.3%) |
Amyotrophic Lateral Sclerosis and other motor neuron diseases (excluding SMA) | 10 (0.9%) |
Idiopathic Neuropathies | 10 (0.9%) |
‘I do not know the name of my disease’ | 8 (0.7%) |
Myofibrillar Myopathies | 6 (0.5%) |
Neuropathies associated with hematological disease and monoclonal gammopathy (MGUS, POEMS, etc.) | 4 (0.4%) |
Skeletal Muscle Channelopathies | 1 (0.1%) |